Last Price Today's Change   Day's Range   Trading Volume
2.58   0.00 (0.00%)  2.58 - 2.60  55,400
Analyze this stock with MQ Trader system


Market Cap: 360 Million
NOSH: 140 Million
Avg Volume (4 weeks):69,843
4 Weeks Range:2.35 - 2.61
4 Weeks Price Volatility (%):
52 Weeks Range:2.29 - 3.39
52 Weeks Price Volatility (%):
Average Price Target: 3.60
Price Target Upside/Downside: +1.02
Stamp duty exempted for year 2019

Financial Highlight

Latest Quarter | Ann. Date 31-Mar-2019 [#1]  |  28-May-2019
Next QR | Est. Ann. Date: 30-Jun-2019  |  13-Aug-2019
T4Q P/E | EY: 12.65  |  7.90%
T4Q DY | Payout %: 2.67%  |  33.81%
T4Q NAPS | P/NAPS: 2.2796  |  1.13
T4Q NP Margin | ROE: 9.71%  |  8.94%


Date Subject
29-May-2019 YSP Southeast Asia - Hit by Higher Cost of Sales
17-May-2019 药剂股研发金额露端倪/黄云浩
16-May-2019 Trading Stocks - Y.S.P. Southeast Asia
15-May-2019 Technical Buy: YSPSAH (7178)
12-May-2019 [转贴] [Y.S.P. SOUTHEAST ASIA HOLDING BHD:更加重视提升营运效率,增加产品注册,有效及更大胆的营销,推广及销售策略,为了在产品销售方面更加重视在线业务,他们已经做了很多努力来提高品牌和产品意识] - James的股票投资James Share Investing
27-Feb-2019 YSP Southeast Asia - Broadly in Line With Expectations
21-Dec-2018 Technical Analysis - Y.S.P. Southeast Asia
21-Nov-2018 YSP Southeast Asia - 9M18 Within Expectations
07-Nov-2018 Technical Analysis - Y.S.P. Southeast Asia
26-Oct-2018 预算案值得关注的个股(四)- 医疗保健
07-Oct-2018 Potential Trade Idea with Pullback Strategy - Y.S.P. Southeast (7178)
03-Oct-2018 Trading Stocks - Y.S.P. Southeast Asia
01-Oct-2018 医药股前景可期?
25-Sep-2018 上升股:永信东南亚阻力RM3.45
25-Sep-2018 Technical Analysis - Y. S. P. Southeast Asia
23-Aug-2018 Technical Analysis - Y.S.P. Southeast Asia
16-Aug-2018 永信东南亚(YSPSAH)- 国内增长推动营收
14-Aug-2018 YSP Southeast Asia - Domestic Growth Surge Boosts 2Q18
14-Aug-2018 YSP Southeast Asia - Domestic Growth Surge Boosts 2Q18
31-Jul-2018 Technical Analysis - Y.S.P. Southeast Asia

Business Background

Y SP Southeast Asia Holding Bhd is an investment company, which engages in the pharmaceutical business, provision of management services. It operates through the following segments: Trading, Manufacturing and Investment Holding. The Trading segment imports, exports, and trades various kinds of pharmaceutical products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. Firm’s majority revenue comes from the Manufacturing segment. Its majority revenue is concentrated in Malaysia.
Trade this stock for as low as 0.05% brokerage. Find out more.

  4 people like this.
ikenduit Borrowing high due to payment hiccup frm govt. System problem but now settle ady. That's what they said in AGM la... Business growing M'sia n Indon.
17/05/2019 12:18 PM
InvestsucessTrader mid stock with good fundamental,
17/05/2019 12:21 PM
mindshare Buy ,i know very well this stock,my son a farmacist inside,
17/05/2019 3:46 PM
InvestsucessTrader Do your own homework before investing, don't expect spoon fed,
17/05/2019 4:01 PM
RainT @mindshare

how many times have you promote said your son work as pharmacist inside ….

so ask your son when YSPSAH share price can touch RM10?
17/05/2019 4:41 PM
mindshare good question Do your own homework before investing, don't expect spoon fed,
17/05/2019 4:56 PM
mindshare Rain T. I quoted from InvestsuccessTrader...At least you spell pharmacist correctly.
17/05/2019 5:00 PM
Jona0724 Kotra also released good QR. That's great
17/05/2019 6:49 PM
InvestsucessTrader some just comments but didn't owned any shares, by the way they post, hahaha,
17/05/2019 9:47 PM
chun2 big sell Q back again
at 2.56/2.57
21/05/2019 3:56 PM
RainT from the last few days I thought that the selling by the (what name WIEFDWIEFBWBFILWQBHFI)

already finish from the share it own

thought I already buy at low price

mana tau , now will come another low maybe

who is the person selling again ?
24/05/2019 12:45 PM
RainT see the revenue , it has been growing in the past 10 years

profit also growing but some years down a little

this prove that this company have some kind of strength and competitive advantage and also it is well manage company
24/05/2019 12:46 PM
RainT not the company directors selling …..

so who...…

when will stop sell...

I want buy at bottom and keep until RM10 lol
24/05/2019 12:49 PM
mindshare apa cerita sekarang?
27/05/2019 10:47 AM
Jona0724 waiting QR. share price sleeping due to market fear and hari raya coming soon?
27/05/2019 3:45 PM
uptrending Tomorrow AGM.. anybody going? Please update us esp on the future prospects...
27/05/2019 10:32 PM
FreedomStrike Any update at AGM?
28/05/2019 1:03 PM
Kalaihselvan Krishnan I don’t understand why some companies wait till the last minute to release results.
28/05/2019 5:05 PM
factorrumour congrats to those who earned a quick profit, good thing i stay away, as the sudden sell down sure indicates something, and thus now reflects in its quarter result
28/05/2019 6:09 PM
uptrending Management guidance on Prospects :

" With the expected challenging times in 2019, the Group will focus on improving operational efficiency, increasing product offerings in the market, effective marketing,
promotional and sales initiatives to gain a more extensive market penetration and to improve the market share.
The preceding years groundwork and efforts to develop the business ahead of time place us in good stead to thrive in the competitive environment. Against this
challenging times, the Group is cautiously optimistic of maintaining its performance in the year AHEAD. "

28/05/2019 6:48 PM
RainT habis….

omg ...now the puzzle is open, on why there have been huge selling recently....

bad quarter result
28/05/2019 6:49 PM
RainT @Kalai

why some companies wait till the last minute to release result ?

1. very likely is a bad result
2. insider want to have time to unload before kill all the ikan bilis
3. management need prepare on how to turn&twist&con investor
4. management need prepare on how to support share price

28/05/2019 6:52 PM
uptrending QR results are released after approval in board meeting.

I noticed that for YSP, the 1Q results (to be released in May) are always released on the same day of the AGM. The board meet after the AGM. They can have 2 meetings in a day.
28/05/2019 7:04 PM
chun2 Oh no.... Profit attributable to equity shareholders fell from 6.7M to 4.8M compared to preceding year corresponding quarter (a drop of 28%) even though revenue up from 71.6M to 74.7M (up 4%)
28/05/2019 7:40 PM
chun2 Looks like FYE2019 is REALLY not going to be easy
28/05/2019 7:42 PM
Fabien "The Efficient Capital Allocater" one weak quarter results and you guys panic? first time investing ar..
28/05/2019 8:09 PM
uptrending Yalor, Fabien, really agree with you. Invest in pharmaceutical company is a long term investment. If we have to react on every QR, it will be a misery..

There is also a change in product mix in the Bangi Plant and the capacity has gone up from what I understand reading the AR 2018.
28/05/2019 8:27 PM
WhereToInvest "This was mainly due to higher cost of goods sold in the period under review." Any idea why the cost increasing?
28/05/2019 9:26 PM
swordwa2 One weak quarter result is fine but the group's prospect does bring some worries
"the Group is cautiously optimistic of maintaining its performance in the year AHEAD"
I read it as maintaining or could be slightly worse performance this year, without much expectation on growth. If this occurs, EPS would fall(lower performance and ESOS dilution)
28/05/2019 10:51 PM
swordwa2 Just voicing out my opinion :)
Anyway, PE of this company is still low comparing to others
28/05/2019 10:55 PM
uptrending Ysp was granted a low PE by the market probably due to low growth. If it can show growth of 20%, at PEG of 1, its PE could shot to 20..

Anyway, its current year dividend, 8.5 cent and NTA, RM2.30 per share is very respectable. In term of Price to Book, it is the lowest among Bursa Pharma company..

It is risky to project full year earning just base on one quarter results..Prior to QR, Dr Neoh's Dynaquest database projected YSP FY19 EPS @23cents.. Now, not sure if it will be revised..
28/05/2019 11:52 PM
Jona0724 Overall still very confident to YSP. Will be top up more if price below NTA. It is very worth use lower cost(below NTA) to be shareholder of YSP.
29/05/2019 8:07 AM
InvestsucessTrader Good or bad times everyone needs medication. nobody can run from it.Defensive stock.
29/05/2019 8:43 AM
uptrending Director exercised 200,000 shares @rm2.55 on 22/04/2019. He must be confident also.
29/05/2019 8:49 AM
shareinvestor88 Sell Sell.TP 1.00
10/06/2019 2:49 AM
RainT 1 day up 1 sen

1 month will up 31 sen
11/06/2019 2:44 PM
mindshare My cost is 3.00....bila mahu breakeven?
11/06/2019 3:06 PM
mindshare 1 day up 1 sen but 1 day can down 40 sen....matilah
11/06/2019 3:07 PM
Fabien "The Efficient Capital Allocater" i prefer this way, slowly but surely. will entitled for 8.5sen end of this month.
11/06/2019 3:09 PM
RainT wah

really this YSPSAH only 1 way ticket only

up only

today up 4 sen
12/06/2019 12:37 PM
RainT @mindshare

buy more now to lower your cost

I have faith in YSPSAH business
12/06/2019 12:38 PM
Fabien "The Efficient Capital Allocater" CIMB target price is 3.40

More runway to go.
12/06/2019 1:50 PM
mindshare @ RainT

I have no more $$ to invest :(
12/06/2019 4:45 PM
RainT @fabien

IB TP cannot trust la

IB TP can trust, shit also can eat already
13/06/2019 11:15 AM
RainT @mindshare

sell underwear , sell house, sell car , sell wife/husband

all in YSPSAH

13/06/2019 11:15 AM
RainT Today drop 4 sen after up up up few days

time to scoop some share ?

will queue to buy another batch
13/06/2019 11:16 AM
mindshare @ RainT

Will ask Ah Long...:)
13/06/2019 11:48 AM
shawn88 Still can buy ?
17/06/2019 11:06 AM
RainT this company trading volume is very low

need to be prepare if u invest in this stock
17/06/2019 3:55 PM
RainT @shawn88

go ask GOD or ask yourself, do your home work and understand more about this company
see the current chart trend now

Overall, YSPSAH biz prospect is quite good as they are in medicine biz
Medicine is quite defensive

if to say fundamental:
cash wise is good, net cash, operating cash flow also is positive
gross profit margin also high at around 40%, ne margin at 5-10%

sales is grow steady throughout the years, profit also steady no big drop or up

at current share price it is not at the peak yet , also not at the lowest point, can say at middle like that

PROBLEM : low trading volume, need to be prepare for this and hold long tem
17/06/2019 4:02 PM


267  377  497  739 

Top 10 Active Counters
 HSI-C5P 0.23+0.005 
 GREATEC 0.90+0.09 
 HSI-H6P 0.32-0.02 
 HSI-C5J 0.14-0.01 
 HSI-H6Q 0.47-0.035 
 EKOVEST 0.835+0.005 
 HSI-H6N 0.195-0.025 
 MYEG 1.39-0.05 
 HPMT 0.44-0.055 
 LAMBO 0.060.00 
Partners & Brokers